07th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170042883 | Methods for Detecting and Treating Rhinovirus Infection | 2017-02-16 |
20170042884 | LIQUID BUPRENORPHINE FORMULATIONS | 2017-02-16 |
20170042885 | Treating Pain In Patients With Hepatic Impairment | 2017-02-16 |
20170042886 | PROCASPASE COMBINATION THERAPY FOR GLIOBLASTOMA | 2017-02-16 |
20170042887 | Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders | 2017-02-16 |
20170042888 | GLYT1 INHIBITORS FOR USE IN THE TREATMENT OF HEMATOLOGICAL DISORDERS | 2017-02-16 |
20170042889 | AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | 2017-02-16 |
20170042890 | METHODS OF REDUCING DECLINE IN VITAL CAPACITY | 2017-02-16 |
20170042891 | AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER | 2017-02-16 |
20170042892 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | 2017-02-16 |
20170042893 | USE OF CASEIN KINASE I INHIBITORS FOR DEPLETING STEM CELLS | 2017-02-16 |
20170042894 | Methods Of Treating Dyskinesia And Related Disorders | 2017-02-16 |
20170042895 | Combination Treatment Comprising Administration of 2-Amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines | 2017-02-16 |
20170042896 | CERDULATINIB FOR TREATING MYELOMA | 2017-02-16 |
20170042897 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | 2017-02-16 |
20170042898 | METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS | 2017-02-16 |
20170042899 | Use of Tetrahydrobiopterine Derivatives in the Treatment and Nutrition of Patients With Amino Acid Metabolic Disorders | 2017-02-16 |
20170042900 | PREVENTIVE AND/OR THERAPEUTIC AGENT OF IMMUNE DISEASE | 2017-02-16 |
20170042901 | METHODS AND COMPOSITIONS FOR INHIBITION OF POLYMERASE | 2017-02-16 |
20170042902 | SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | 2017-02-16 |
20170042903 | Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache | 2017-02-16 |
20170042904 | METHODS FOR TREATING T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | 2017-02-16 |
20170042905 | Prostaglandin Receptor EP2 Antagonists, Derivatives, Compositions, and Uses Related Thereto | 2017-02-16 |
20170042906 | FATTY ACID CONJUGATES OF QUETIAPINE, PROCESS FOR MAKING AND USING THE SAME | 2017-02-16 |
20170042907 | PENTAAZA MACROCYCLIC RING COMPLEXES POSSESSING ORAL BIOAVAILABILITY | 2017-02-16 |
20170042908 | METHOD FOR TREATING GEOGRAPHIC ATROPHY ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION | 2017-02-16 |
20170042909 | NEURO-PROTECTIVE AGENTS AND USES THEREOF (As Amended) | 2017-02-16 |
20170042910 | PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY | 2017-02-16 |
20170042912 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER | 2017-02-16 |
20170042913 | USE OF 2-METHYLENE-19-NOR-(20S)-1ALPHA,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM IN PATIENTS PREVIOUSLY TREATED WITH CALCIMIMETICS | 2017-02-16 |
20170042914 | Osteoclast Inhibitors for Knee Conditions | 2017-02-16 |
20170042915 | LPA RECEPTOR MODULATORS FOR BROWN FAT DIFFERENTIATION | 2017-02-16 |
20170042916 | ANIMAL TISSUE COLONIZATION AND TREATMENT OF INFECTION | 2017-02-16 |
20170042917 | SUBSTITUTED BICYCLIC COMPOUNDS | 2017-02-16 |
20170042918 | METHOD OF IMPROVING SKILLS WITH A COMPOSITION COMPRISING NON-DIGESTIBLE SACCHARIDE | 2017-02-16 |
20170042919 | Analogs of N-Acetlyglucosamine and Uses Thereof | 2017-02-16 |
20170042920 | Guanosine as an Immune Potentiator Mediated Through Toll Receptors | 2017-02-16 |
20170042921 | METHOD FOR TREATING HIV | 2017-02-16 |
20170042922 | SITAGLIPTIN TANNATE COMPLEX | 2017-02-16 |
20170042923 | REDUCED TOXICITY MOLECULAR CONJUGATES OF ANTI-FUNGAL AGENTS | 2017-02-16 |
20170042924 | MUSCLE ATROPHY INHIBITOR CONTAINING QUERCETIN GLYCOSIDE | 2017-02-16 |
20170042925 | GLYCOSIDE DERIVATIVES AND USES THEREOF | 2017-02-16 |
20170042926 | TREATING OCULAR NEOVASCULARIZATION | 2017-02-16 |
20170042927 | EFFECTIVE TREATMENT OF OVARIAN CANCER USING TRICIRIBINE AND RELATED COMPOUNDS | 2017-02-16 |
20170042928 | Edible Energy Composition | 2017-02-16 |
20170042929 | Methods of Treating Neurological Diseases | 2017-02-16 |
20170042930 | METHOD OF TREATING A DISEASE USING A GLYCOLYTIC DEPENDENT COMPOUND | 2017-02-16 |
20170042931 | METHODS TARGETING MIR-128 FOR REGULATING CHOLESTEROL/LIPID METABOLISM | 2017-02-16 |
20170042932 | Hydroxypropyl Beta-Cyclodextrin Compositions and Methods | 2017-02-16 |
20170042933 | OPHTHALMIC COMPOSITIONS COMPRISING POLYETHER SUBSTITUTED POLYMERS | 2017-02-16 |
20170042934 | Materials and Methods Relating to Stabilised Polymeric Silicate Compositions | 2017-02-16 |
20170042935 | MAGNESIUM OXIDE GRANULES FOR PHARMACEUTICAL APPLICATIONS OR FOR USE AS FOOD ADDITIVES | 2017-02-16 |
20170042936 | COMPOSITION FOR LOCAL AND CONTROLLED RELEASE OF DRUGS AND METHODS THEREOF | 2017-02-16 |
20170042937 | DEEP SEA WATER EXTRACT AND USE THEREOF | 2017-02-16 |
20170042938 | MODIFICATION OF EXTRACORPOREAL PHOTOPHERISIS TECHNOLOGY WITH PORPHYRIN PRECURSORS | 2017-02-16 |
20170042939 | NKT-LIKE CELL SUBPOPULATION AND METHOD OF USING THE SAME IN THE TREATMENT OF TUMOR | 2017-02-16 |
20170042940 | COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION | 2017-02-16 |
20170042941 | A PHARMACEUTICAL COMPOSITION COMPRISING A SUSPENSION OF TOTAL CELLS OBTAINED FROM HAIR FOLLICLE AND PLASMA DERIVED GROWTH FACTORS FOR PROMOTING HAIR FOLLICLE REGENERATION | 2017-02-16 |
20170042942 | Pancreatic Islets of Transgenic LEA29Y Animals for Treating Diabetes | 2017-02-16 |
20170042943 | LIQUID AMNION TRANSPLANT PRODUCT | 2017-02-16 |
20170042944 | TREATMENT OF CONDITIONS AND COMPLICATIONS IN INFANTS | 2017-02-16 |
20170042945 | METHOD FOR TREATING OR PREVENTING A PANCREATIC DYSFUNCTION | 2017-02-16 |
20170042946 | LOBSTER HEMOLYMPH AS A UTILITY FOR THE TREATMENT OF MAMMALIAN TISSUE LESIONS | 2017-02-16 |
20170042947 | UNSATURATED FATTY ACID ABSORPTION ACCELERATOR | 2017-02-16 |
20170042948 | MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT | 2017-02-16 |
20170042949 | SYSTEM AND METHOD FOR PRODUCTION OF SHELF STABLE PROBIOTICS FOR ANIMAL NUTRITION ENHANCEMENT | 2017-02-16 |
20170042950 | MATERIALS AND METHODS FOR IMPROVING GASTROINTESTINAL HEALTH | 2017-02-16 |
20170042951 | THERAPY FOR USE IN THE TREATMENT OF TUMORS, ACQUIRED IMMUNODEFICIENCY SYNDROME AND LEUKEMIAS BY DUAL IMMUNE BIOSTIMULATION | 2017-02-16 |
20170042952 | PROCESS FOR REMOVING PESTICIDES FROM GINKGO BILOBA EXTRACTS, AND EXTRACTS OBTAINABLE BY SAID PROCESS | 2017-02-16 |
20170042953 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION USING ACETYL-L-CARNITINE, HUPERZINE A AND GINKGO BILOBA | 2017-02-16 |
20170042954 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION USING ACETYL-L-CARNITINE, HUPERZINE A, GINKGO BILOBA, AND VITAMIN B COMPLEX | 2017-02-16 |
20170042955 | Novel Anti-Fungal Composition | 2017-02-16 |
20170042956 | EMBELIA CONCINNA EXTRACT COMPRISING FLAVONOIDS IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2017-02-16 |
20170042957 | MANGIFERA INDICA AS A SIRTUIN 1 ACTIVATING AGENT | 2017-02-16 |
20170042958 | METHODS OF REDUCING SKIN INFLAMMATION USING COMPOSITIONS COMPRISING AMPELOPSIS GROSSEDENTATA AND ALBIZIA JULIBRISSIN EXTRACTS | 2017-02-16 |
20170042959 | Composition for the treatment of burns, diabetic wounds, other types of wounds and subsequent lys greatly reduced scarring | 2017-02-16 |
20170042960 | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B | 2017-02-16 |
20170042961 | METHODS FOR TREATING HCV | 2017-02-16 |
20170042962 | AGENT FOR PREVENTING OR AMELIORATING VASCULAR ENDOTHELIAL MALFUNCTION | 2017-02-16 |
20170042963 | ANTICANCER PEPTIDE FOR INHIBITING PROLIFERATION OF CANCER STEM CELLS AND USE THEREOF | 2017-02-16 |
20170042964 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HYPERLIPIDEMIA, FATTY LIVER, ATHEROSCLEROSIS AND OTHER DISORDERS ASSOCIATED WITH METABOLIC SYNDROME | 2017-02-16 |
20170042965 | COMPOSITIONS AND USES OF ANTIMICROBIAL MATERIALS WITH TISSUE-COMPATIBLE PROPERTIES | 2017-02-16 |
20170042966 | AGENTS AND METHODS OF TREATMENT | 2017-02-16 |
20170042967 | TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS | 2017-02-16 |
20170042968 | ISOFORM NELL-1 PEPTIDE | 2017-02-16 |
20170042969 | PEPTIDES DERIVED FROM RS1 WHICH DOWN-REGULATE GLUCOSE ABSORPTION AFTER A GLUCOSE RICH MEAL AND INCREASE INSULIN SENSITIVITY | 2017-02-16 |
20170042970 | USE OF PEPTIDE FOR TREATING ANGIOGENESIS-RELATED DISEASES | 2017-02-16 |
20170042971 | STABLE MIA/CD-RAP FORMULATION | 2017-02-16 |
20170042972 | USE OF CTLA4 COMPOUND FOR ACHIEVING DRUG-FREE REMISSION IN SUBJECTS WITH EARLY RA | 2017-02-16 |
20170042973 | COMPOSITIONS AND METHODS FOR MODULATING STEM CELLS AND USES THEREOF | 2017-02-16 |
20170042974 | TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERON | 2017-02-16 |
20170042975 | Peptides for the Treatment of Cancer | 2017-02-16 |
20170042976 | METAL-GLYCOPROTEIN COMPLEXES AND PHOTODYNAMIC THERAPY OF IMMUNE PRIVILEGED SITES WITH SAME | 2017-02-16 |
20170042977 | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE | 2017-02-16 |
20170042978 | CNS DELIVERY OF THERAPEUTIC AGENTS | 2017-02-16 |
20170042979 | TARGETING OF GLYCOPROTEIN THERAPEUTICS | 2017-02-16 |
20170042980 | Degradation of Beta-Amyloid Proteins With Keratinase | 2017-02-16 |
20170042981 | HALF-LIFE EXTENDED FACTOR FVIIA PROTEIN FOR PREVENTION AND TREATMENT OF BLEEDING AND DOSING REGIMENS THEREFOR | 2017-02-16 |
20170042982 | Treatment of abnormal cutaneous scarring | 2017-02-16 |
20170042983 | LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS | 2017-02-16 |